Abstract. Extracts from human leukocytes have been examined for the enzymes of de novo fatty acid biosynthesis. These extracts do not catalyze the synthesis of long-chain fatty acids because they lack acetyl CoA carboxylase, the first enzyme unique to the fatty acid synthesis pathway.
Introduction
The mechanism of fatty acid biosynthesis de novo has recently been elucidated through studies of yeast, mammals, and E. coli (for review see 1, 2) . In the first reaction unique to this pathway, acetyl CoA is carboxylated to form malonyl CoA. This reaction is catalyzed by acetyl CoA carboxylase, a biotin enzyme, which is the rate-limiting enzyme in in vitro fatty acid biosynthesis measured in extracts from rat liver and adipose tissue.
The subsequent reactions of fatty acid synthesis occur with the substrates bound to the sulfhydryl group of 4'-phosphopantethine, the prosthetic group of the acyl carrier protein which, in mammals, is a part of a "soluble" multienzyme complex which is designated fatty acid synthetase.
Examination of fatty acid synthesis in leukocytes was undertaken since these cells provide a ready source of material for studies of lipid metabolism in humans under various metabolic conditions. Previous studies have shown that mature erythrocytes are unable to synthesize fatty acids because of a lack of acetyl CoA carboxylase (3) . Incubation of blood (intact cells) with acetate-14C results in the incorporation of acetate-'4C into leukocyte fatty acids, but the enzymatic mechanism of this incorporation has not been elucidated (4) (5) (6) (7) . Therefore, extracts of leukocytes from normal volunteers and from patients with various hematologic diseases have been examined for the enzymes of fatty acid synthesis; 1596
Methods
Blood samples were collected from healthy volunteers and from patients, without regard to diet, in plastic syringes or bags. The blood was anticoagulated with either EDTA or ACD; total and differential white blood cell count, hemoglobin concentration, hematocrit value and enumeration of erythrocytes, reticulocytes, and platelets were performed on all samples by standard techniques. Leukocytes and platelets were separated from erythrocytes by the dextran flotation technique of Skoog and Beck (8) . Plastic equipment or siliconized glassware was used for all procedures. The platelets were removed by sedimentation of the leukocytes at 100 g for 7 min at 40C in a Sorvall refrigerated centrifuge. The pellet of leukocytes was then mixed with distilled water for 30 sec to lyse the few remaining erythrocytes. After restoring the suspension to isotonicity with saline, the leukocytes were recovered by sedimentation at 500 g for 7 min and the hemoglobin containing supernatant solution was discarded. Leukocytes at a concentration of 50,000-500,000 WBC/mmn were suspended in a solution containing 0.76% NaCl, 0.039% KCl, 0.15% MgCl2_ 6 H20, 0.1%0 glucose, and 0.02 M Tris-HCl (pH 7.3).
RBC, WBC, and platelet counts were performed on this cell suspension. These leukocyte preparations contained 0-2 RBC/103 WBC and 0-5 platelets/WBC. Subsequent studies with platelets and erythrocytes indicated that this level of contamination does not significantly affect the estimation of fatty acid synthesis in the leukocyte preparations. After counts were obtained, the leukocytes were again collected by sedimentation and resuspended in a solution containing 0.01 M imidazole-HCl (pH 7.2), 0.25 M sucrose, and 0.01 M 2-mercaptoethanol.
The leukocytes were then ruptured by sonic oscillation in a Biosonik sonifier for 1 min at 50%o intensity with a microprobe while being maintained in an ice bath. More than 99%o of the cells were ruptured by this procedure.
The sonicate was centrifuged at 49,000 g for 30 min and the supernatant solution was used for studies of fatty acid synthesis.
Fatty acid synthetase assay. Fatty acid synthetase was measured by a modification of the method of Martin, Horning, and Vagelos (9) . Reaction mixtures contained 50 ,umoles imidazole-HCl (pH 6.8), 10 ,umoles 2-mercaptoethanol, 0.75 ,umole NADP, 1.5 ,umoles glucose 6-phosphate, 0.5 unit of glucose 6-phosphate dehydrogenase,l 0.07 ,mole acetyl CoA, and 0.06 ,mole malonyl CoA and extract in a final volume of 0.5 ml.
Either malonyl CoA-2-"C (1 ,uc/,mole) or acetyl CoA-1-14C (5 uc/humole) was labeled in these reactions. Reaction mixtures were incubated for 45 min at 30'C and the reactions were stopped by the addition of 1.0 ml of 3 N HCO in 50% ethanol. Next, 2.5 ml of hexane was added and, after extraction, the hexane layer was evaporated under a stream of nitrogen at 600C. The fatty acids were again dissolved in hexane and counted in a liquid scintillation counter in Bray's solution (10) . Pre (11), respectively. Total lipids were extracted from leukocytes by the method of Folch, Lees, and Sloane Stanley (12), and after hydrolysis in 2 N methanolic KOH for 2 hr at 70°C, aliquots were subjected to Schmidt degradation by the method of Brady, Bradley, and Trams (13) . In these degradations, 1 ,umole of palmitic acid was added as a carrier to each reaction mixture. Palmitic acid-1-"C 1 was added to duplicate flasks as an internal standard and recoveries were from 80-95%o. Acetyl CoA-1-'C and nonradioactive acetyl CoA were prepared by the method of Simon and Shemin (14) . Malonyl CoA and malonyl CoA-2-"'C were prepared by the method of Trams and Brady (15) and purified on DEAE cellulose columns. Sodium acetate-1-L4C, acetic anhydride-1-"C, and malonic acid-2-"C were purchased from New England Nuclear Corp.
Results Fatty acid synthetase. Extracts of leukocytes were found to contain fatty acid synthetase activity which has the same requirements as that in other systems (Table I ). The incomplete dependence of the reaction on acetyl CoA is probably due to the formation of small amounts of acetyl CoA from malonyl CoA through the action of malonyl CoA decarboxylase. The pH optimum of the leukocyte synthetase is 6.6 which is quite similar to that of rat liver or adipose tissue. The stoichiometry of the fatty acid synthetase is shown in probably the major product in the leukocyte fatty acid synthetase reaction since an average of 6.9 moles of malonate/mole of acetate are incorporated. Palmitate is also the major product of fatty acid synthesis in human liver (16 10 min before the addition of the other components of the reaction mixture. In Experiment 1, a large excess of purified rat adipose tissue fatty acid synthetase was added to the reaction mixture. In each experiment, 5 of the fatty acids formed were assayed for radioactivity and the remainder was used for Schmidt degradation.
novo synthesis as was shown by Schmidt degradation of the extracted fatty acids. This technique, which removes the carboxyl carbon of fatty acids (C-1) as CO2, may be used to distinguish between de novo fatty acid synthesis and chain elongation of preformed fatty acids. In de novo synthesis starting with acetyl CoA-1-14C alternate carbon atoms will be labeled throughout the chain startinig with C-1. Therefore, palmitate formed in this manner will contain 1/8 (12.5%) of the label in the C-1 position. The chain elongation pathway utilizes acetyl CoA instead of malonyl CoA and adds C, units of preformed, long-chain fatty acids. Usually only one or two acetyl groups are added to the fatty acid so that starting with acetyl CoA-1-'4C most of the counts will be in the C-1 position. Thus, as shown in Table III , Experi- (20) .
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In order to confirm this conclusion, we incubated intact leukocytes with sodium acetate-1-14C. Since leukocytes are unable to synthesize fatty acids, it is necessary to explain the incorporation of acetate-14C obtained by Marks, Gellhorn, and Kidson and others (4) (5) (6) (7) . Recent experiments of Mlliras, Mantzos, and Levis (17) suggest that most of the label incorporated under these conditions is by the pathway of chain elongation of preformed fatty acids. The results of these intact cell experiments, shown in Table IV , confirm that acetate has been incorporated into fatty acids by chain elongation. The fatty acids formed in Experiment 2 were further studied by gas-liquid chromatography of the methyl esters (Table V) . Over 90% of the radioactive fatty acids formed were of C18 or longer chain length. The product of the de novo synthetic pathway, palmitate (C16), contained only 3.2%o of the acetate incorporated. This labeling pattern and the fact that most of the counts incorporated are in the C-1 position indicate that acetate is being incorporated into fatty acids by the chain-elongation pathway and that the de novo synthetic pathway is inoperative.
Fatty acid synthetase activity. Fatty acid synthetase activity was easily demonstrable in the leukocytes from all of the subjects tested despite the persistent absence of acetyl CoA carboxylase activity (Table VI) . There was no substantial difference in the results when expressed per cell rather than per mg soluble protein. The yield of soluble protein ranged from 1 to 2 mg per 108 cells. No correlation was found between the level of synthesis and contamination by blood platelets; also, no correlation was found between the per- (18) and 20%o of the radioactivity was found to cochromatograph with the carrier malonyl CoA. This peak was pooled and further identified as malonyl CoA by ascending paper chromatography on Whatmann 1 paper in NH4OH: isobutyric acid: water (3.7:57.7: 38.5). A portion of the isolated radioactive product was also hydrolyzed in 0.1 N NaOH at 370C for 1 hr. The malonic acid formed was identified by ascending paper chromatography on Whatmann 1 paper in ethyl ether: acetone: acetic acid: water (6: 6: 3: 1). Thus it was clearly established that these leukemic blasts contain a low level of acetyl CoA carboxylase. Extracts from these blasts were incubated with acetyl CoA-1-_4C and the acetyl CoA carboxylase cofactors in the fatty acid-synthesizing system and the fatty acids formed were submitted to Schmidt degradation. In this case, 11%o of the counts incorporated were in the C-1 position indicating de novo synthesis of fatty acids from acetyl CoA.
The acetyl CoA carboxylase activity in this extract was 5 ",.Lmoles malonyl CoA formed/mg of protein per min while the fatty acid synthetase activity was 152 ,umoles malonyl CoA incorporated/ mg of protein per min. Thus, acetyl CoA carboxylase is rate-limiting in this system as it is in fatty acid biosynthesis in rat liver and adipose tissue. Two additional patients with acute leukemia were studied, and in each case acetyl CoA carboxylase activity was present at levels similar to those noted above. In both of these patients more than 50%o of the leukocytes in the blood were blast cells. Thus in three of the four patients with acute leukemia, acetyl CoA carboxylase activity was present in low levels and thus provided a complete fatty acid-synthesizing system in the blast cells. Discussion That mature erythrocytes are unable to synthesize fatty acids de novo is not surprising since 14 moles of NADPH are required to form 1 mole of palmitate. Since the erythrocyte cannot respire and is thus relatively deficient in reducing power, it might be suspected that active fatty acid synthesis would not occur in this cell. The leukocyte, however, is capable of active respiration, and it is somewhat surprising that this cell cannot synthesize fatty acids, The enzyme missing in both erythrocytes and leukocytes is acetyl CoA carboxylase which is the first enzyme unique to the fatty acid synthesis pathway.
Erythrocytes and leukocytes contain fatty acid synthetase activity, but in the absence of a source of malonyl CoA the fatty acid synthetase in both is presumably nonfunctional. It is possible that primitive hematopoietic cells have the capacity to form fatty acids and that this capacity is lost as acetyl CoA carboxylase activity decreases during maturation. By this hypothesis, the fatty acid synthetase activity measured in mature leukocytes and erythrocytes would be that due to vestigial enzyme which presumably turns over slowly. To test this hypothesis requires a source of primitive hematopoietic cells free of fat cells. The low levels of acetyl CoA carboxylase found in patients with acute leukemia and large numbers of primitive blast cells suggest that this hypothesis may be correct. Whether this observation reflects the enzyme content of normal stem cells or whether it is peculiar to the leukemic blast cell is unresolved.
The inability of leukocytes and erythrocytes to synthesize fatty acids raises a question as to how these cells are able to maintain the complement of complex lipids which are required for cell membranes as well as for other cell structures and functions. Possibly these cells are capable of activating fatty acids transported from plasma and thus can use preformed fatty acids for complex lipid biosynthesis. Recent experiments by Wittels and Hochstein (19) suggest that erythrocytes may be capable of transporting previously activated, long-chain fatty acids by way of palmityl carnitine transferase which is contained in erythrocyte membranes.
